Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Zezhong Liu, Wei Xu, Shuai Xia, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 190

Showing 26-50 of 190 citing articles:

MPLA-Adjuvanted Liposomes Encapsulating S-Trimer or RBD or S1, but Not S-ECD, Elicit Robust Neutralization Against SARS-CoV-2 and Variants of Concern
Jian Wang, Xuguang Yin, Yu Wen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 3563-3574
Closed Access | Times Cited: 28
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 16
Enhancing vaccine half-life as a novel strategy for improving immune response durability of subunit vaccines
Zhaoling Shen, Cheng Li, Wenping Song, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012845-e1012845
Open Access
Quality by design for transient RBD-Fc fusion protein production in Chinese hamster ovary cells
Araya Jivapetthai, Wanatchaporn Arunmanee, Natapol Pornputtapong
Biotechnology Reports (2025) Vol. 45, pp. e00882-e00882
Open Access
A SARS-CoV-2 vaccine on an NIR-II/SWIR emitting nanoparticle platform
Yongbo Jiang, Mrinmoy Sanyal, Noor Hussein, et al.
Science Advances (2025) Vol. 11, Iss. 6
Open Access
Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats
Cenrong Wang, Xin Tang, Chenghan Jiang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Precision mapping of the functional epitope of a SARS-CoV-2 neutralizing antibody via hydrogen–deuterium exchange mass spectrometry
Ji Woong Kim, In Young Ko, Ha Gyeong Shin, et al.
Microchemical Journal (2025), pp. 113187-113187
Closed Access
The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
Manish Dhawan, Nanamika Thakur, Manish Sharma, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117936-117936
Closed Access
SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways
Daniel Mekonnen, Hylemariam Mihiretie Mengist, Tengchuan Jin
Expert Review of Vaccines (2021) Vol. 21, Iss. 1, pp. 69-81
Open Access | Times Cited: 38
Highly susceptible SARS-CoV-2 model in CAG promoter–driven hACE2-transgenic mice
Masamitsu N. Asaka, Daichi Utsumi, Haruhiko Kamada, et al.
JCI Insight (2021) Vol. 6, Iss. 19
Open Access | Times Cited: 32
A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern
Jingyi Yang, Meiqin Liu, Lin Liu, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 11, pp. 1279-1289
Open Access | Times Cited: 26
Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant
Naru Zhang, Qianting Ji, Zezhong Liu, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 501-501
Open Access | Times Cited: 25
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting
Blake M. Hauser, Maya Sangesland, Kerri St. Denis, et al.
Cell Reports (2022) Vol. 38, Iss. 12, pp. 110561-110561
Open Access | Times Cited: 25
Hydrogel microcapsules containing engineered bacteria for sustained production and release of protein drugs
Yu Chang, Xinyu Zhang, Gaoju Pang, et al.
Biomaterials (2022) Vol. 287, pp. 121619-121619
Closed Access | Times Cited: 24
Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant
Waranyoo Phoolcharoen, Balamurugan Shanmugaraj, Narach Khorattanakulchai, et al.
Vaccine (2023) Vol. 41, Iss. 17, pp. 2781-2792
Open Access | Times Cited: 13
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
Georgia Deliyannis, Nicholas A. Gherardin, Chinn Yi Wong, et al.
EBioMedicine (2023) Vol. 92, pp. 104574-104574
Open Access | Times Cited: 13
Rapid detection of SARS-CoV-2 spike protein using a magnetic-assisted electrochemical biosensor based on functionalized CoFe2O4 magnetic nanomaterials
Bing Zhao, Chan-ru Xiong, Yao Liu, et al.
Talanta (2024) Vol. 274, pp. 125986-125986
Closed Access | Times Cited: 4
Single‐dose immunisation with a multimerised SARS‐CoV‐2 receptor binding domain (RBD) induces an enhanced and protective response in mice
Ralf Salzer, Jordan J. Clark, Marina Vaysburd, et al.
FEBS Letters (2021) Vol. 595, Iss. 18, pp. 2323-2340
Open Access | Times Cited: 31
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope
Zezhong Liu, Wei Xu, Zhenguo Chen, et al.
Protein & Cell (2021) Vol. 13, Iss. 9, pp. 655-675
Open Access | Times Cited: 31
Recombinant production of a functional SARS-CoV-2 spike receptor binding domain in the green algae Chlamydomonas reinhardtii
Anthony Berndt, Tressa N. Smalley, B Ren, et al.
PLoS ONE (2021) Vol. 16, Iss. 11, pp. e0257089-e0257089
Open Access | Times Cited: 31
A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases
Jie Zhou, Wei Xu, Zezhong Liu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 1652-1661
Open Access | Times Cited: 30
Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant
Wanbo Tai, Benjie Chai, Shengyong Feng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 21
Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines
Jie Zhou, Zezhong Liu, Guangxu Zhang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21
Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes
Ola Diebold, Victoria Gonzalez, Luca Venditti, et al.
Journal of Virology (2022) Vol. 96, Iss. 14
Open Access | Times Cited: 18
Identification of an immunodominant neutralizing epitope of porcine Deltacoronavirus spike protein
Rui Chen, Yimin Wen, Enbo Yu, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 125190-125190
Closed Access | Times Cited: 11

Scroll to top